To include your compound in the COVID-19 Resource Center, submit it here.

Celldex raises $31.5 million

Celldex Therapeutics Inc. (NASDAQ:CLDX) raised $31.5 million through the sale of

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE